The FDA has recently published a Recommended Acceptable Limit guidance document for nitrosamine impurities in drug products....
Per- and poly-fluoroalkyl substances (PFAS) are a group of fluorinated compounds characterized by carbon-fluorine bonds. While some...
If you are keeping abreast of FDA’s medical device efforts, then you know that as of October...
The new version of ISO 10993-17 is expected to be published very soon. This is a major...
Can the safe history of clinical use (no complaints registered in PMS) be used as justification not...
A Clinical Evaluation Report (CER) is a detailed summary of the evaluation of information pertaining to clinical...
Successful quality system remediation relies on understanding why problems arose, generally referred to as “root cause analysis.” ...
FDA Warning Letters are devastating – a Quality Manager’s worst nightmare – a major shock to any...
Devices already legally on the market under the European Union’s (EU) Medical Devices Directive (MDD) or the...
Have you been issued an FDA Form 483 or Warning Letter? We can relate to how stressful...
The European Medical Device Regulation (MDR) is a new set of regulations that will become effective May...
Compared to the Medical Device Directive (MDD) 93/42/EEC, the Medical Device Regulation (MDR) No. 2017/745 introduces a...
OUR COMMITTMENT
We are committed to consistently performing services with high quality, that deliver exceptional results, and add value to the client’s business.
For client surveys sent in the last two quarters, we received ratings of 5/5 points (10).